Back to main page

DREAM Module Identification Challenge – Consensus modules

PPI-STRING_Consensus_mod219

Assigned name NA
Network PPI-STRING
Module ID PPI-STRING_Consensus_mod219
Module size 25 genes

Module genes

This module comprises the following genes:

Gene ID Gene Symbol Gene Name
170691

ADAMTS17 ADAM metallopeptidase with thrombospondin type 1 motif 17
79747

ADGB androglobin
11132

CAPN10 calpain 10
11131

CAPN11 calpain 11
147968

CAPN12 calpain 12
92291

CAPN13 calpain 13
440854

CAPN14 calpain 14
824

CAPN2 calpain 2
825

CAPN3 calpain 3
726

CAPN5 calpain 5
827

CAPN6 calpain 6
23473

CAPN7 calpain 7
388743

CAPN8 calpain 8
10753

CAPN9 calpain 9
29082

CHMP4B charged multivesicular body protein 4A
92421

CHMP4C charged multivesicular body protein 4C
79643

CHMP6 charged multivesicular body protein 6
353288

KRT26 keratin 26
54799

MBTD1 mbt domain containing 1
10015

PDCD6IP programmed cell death 6 interacting protein
114822

RHPN1 rhophilin Rho GTPase binding protein 1
85415

RHPN2 rhophilin Rho GTPase binding protein 2
6650

SOLH calpain 15
53349

ZFYVE1 zinc finger FYVE-type containing 1
84936

ZFYVE19 zinc finger FYVE-type containing 19

Functional annotation

Modules were tested for enrichment in functional and pathway annotations using two complementary approaches:
1. To select a small number of specific / non-redundant annotations for each module, a regression-based approach was used;
2. To obtain the complete set of enriched annotations, an extension of Fisher’s exact test that takes annotation bias into account was employed (Wallenius’ non-central hypergeometric distribution).

Most specific annotations for this module

Coeff.1P-value.2Source.3Term.4Class.5
5.40e-01 3.54e-30 GO calcium-dependent cysteine-type endopeptidase activity

molecular_function
7.77e-02 6.89e-09 GO cell separation after cytokinesis

biological_process
4.31e-02 6.70e-05 Reactome RHO GTPases Activate Rhotekin and Rhophilins

Signal Transduction
2.56e-02 8.64e-07 GO vacuolar transport

biological_process
1.41e-02 1.73e-08 GO viral budding via host ESCRT complex

biological_process

1Regression coefficient

2Fisher’s exact test nominal P-value

3Annotation source (Reactome, GO biological process (BP), molecular function (MF) and cellular component (CC))

4GO category or Reactome pathway

5High-level branch of annotation tree

Gene membership

All enriched annotations

Gene Ontology

P-value1 FDR2 Term
0.00e+00 0.00e+00 cysteine-type endopeptidase activity

0.00e+00 0.00e+00 endopeptidase activity

0.00e+00 0.00e+00 cysteine-type peptidase activity

0.00e+00 0.00e+00 calcium-dependent cysteine-type endopeptidase activity

0.00e+00 0.00e+00 peptidase activity

2.74e-08 1.68e-05 cell separation after cytokinesis

4.42e-08 2.64e-05 viral budding via host ESCRT complex

5.61e-08 3.30e-05 viral budding

8.55e-08 4.89e-05 multivesicular body assembly

1.20e-07 6.70e-05 multivesicular body organization

1.20e-07 6.70e-05 multi-organism membrane organization

1.69e-07 9.18e-05 virion assembly

3.39e-07 1.75e-04 mitotic metaphase plate congression

4.75e-07 2.40e-04 ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway

4.96e-07 2.50e-04 metaphase plate congression

8.68e-07 4.18e-04 endosome organization

1.06e-06 3.09e-04 ESCRT III complex

1.64e-06 7.49e-04 establishment of chromosome localization

3.25e-06 1.40e-03 regulation of mitotic spindle assembly

3.61e-06 1.54e-03 mitotic sister chromatid segregation


11Nominal enrichment p-value (Wallenius’ noncentral hypergeometric distribution)

2FDR corrected p-value (Benjamini-Hochberg)

Reactome

P-value1 FDR2 Term
2.32e-06 3.81e-04 ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT
6.05e-06 1.20e-03 ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT
8.34e-06 1.26e-03 MEMBRANE TRAFFICKING
3.12e-04 4.25e-02 MEMBRANE TRAFFICKING

11Nominal enrichment p-value (Wallenius’ noncentral hypergeometric distribution)

2FDR corrected p-value (Benjamini-Hochberg)

Mouse mutant phenotypes

P-value1 FDR2 Term
6.52e-04 7.08e-01 increased susceptibility to injury

1.87e-03 1.00e+00 skeletal muscle degeneration

1.87e-03 1.00e+00 abnormal rib-vertebral column attachment

3.74e-03 1.00e+00 abnormal gastrocnemius morphology

3.74e-03 1.00e+00 abnormal skeletal muscle regeneration

3.75e-03 1.00e+00 abnormal interparietal bone morphology

3.75e-03 1.00e+00 abnormal tongue muscle morphology

5.61e-03 1.00e+00 pale placenta

5.61e-03 1.00e+00 abnormal soleus morphology

5.62e-03 1.00e+00 abnormal occipital bone morphology

7.47e-03 1.00e+00 abnormal tibialis anterior morphology

7.48e-03 1.00e+00 abnormal cervical axis morphology

7.49e-03 1.00e+00 transmission ratio distortion

7.49e-03 1.00e+00 abnormal thoracic cage morphology

7.50e-03 1.00e+00 abnormal vertebral column morphology

7.50e-03 1.00e+00 abnormal liver development

7.52e-03 1.00e+00 liver hypoplasia

9.36e-03 1.00e+00 rib bifurcation

1.12e-02 1.00e+00 abnormal cervical atlas morphology

1.30e-02 1.00e+00 abnormal sarcolemma morphology


11Nominal enrichment p-value (Wallenius’ noncentral hypergeometric distribution)

2FDR corrected p-value (Benjamini-Hochberg)


Generated on: Thu Aug 30 17:30:35 2018 - R2HTML